Expression of VEGF(121) in gastric carcinoma MGC803 cell line - PubMed (original) (raw)

Expression of VEGF(121) in gastric carcinoma MGC803 cell line

Jun-Tian Xue et al. World J Gastroenterol. 2000 Apr.

No abstract available

PubMed Disclaimer

Figures

Figure 1

Figure 1

Neutralization of 5C5 to the VEGF-induced HUVEC growth.n: no VEGF or antibody added, 0.10: VEGF 2 mg/L and antibody 5C5 in various concentration were added.

Figure 2

Figure 2

RT-PCR of VEGF121 cDNA and identific ation of recombinant PGEX2T-VEGF.1: 585/985 bp DNA marker, 2: PCR product of VEGF from MGC803 cells, 3: PCR product of VEGF from HUVEC, 4: PGEX2T-VEGF digested with _Bam_-H I/_Eco_-R I.

Figure 3

Figure 3

SDS-PAGE analysis of GST-VEGF expressed in E. coli XL-1 blue-1. Standards of protei nmolecular weight, 2. Total proteins from bacterial transformed with PGEX2T-VEGF121 without induced IPTG, 3. Proteins from bacterial induced by IPTG, 4. Protein pellet of bacterial lysis without induced IPTG, 5. Protein pellet of bacterial lysis induced by IPTG.

Figure 4

Figure 4

Western blot analysis of the bacterial expr essed GST-VEGF121 by 5C5.1. Standards of protei nmolecular weight, 2. Uninduced bacterial protein treated with 5C5, 3. Induced bacterial protein treated with 5C5, 4. Induced bacterial protein treated with normal mouse IgG.

Similar articles

Cited by

References

    1. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 1989;84:1470–1478. - PMC - PubMed
    1. Asano M, Yukita A, Matsumoto T, Matsuo K, Kondo S, Suzuki H. Isolation and characterization of neutralizing monoclonal antibodies to human vascular endothelial growth factor/vascular permeability factor121 (VEGF/VPF121) Hybridoma. 1995;14:475–480. - PubMed
    1. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 1993;362:841–844. - PubMed
    1. Wizigmann-Voos S, Breier G, Risau W, Plate KH. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res. 1995;55:1358–1364. - PubMed
    1. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 1992;359:845–848. - PubMed

LinkOut - more resources